Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

9.96
Delayed Data
As of Aug 28
 +0.22 / +2.26%
Today’s Change
4.83
Today|||52-Week Range
12.75
+49.10%
Year-to-Date
No recent news for Cancer Genetics Inc.

Today’s Trading

Previous close9.74
Today’s open9.65
Day’s range9.65 - 10.35
Volume25,958
Average volume (3 months)64,737
Market cap$98.1M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+50.55%
Earnings growth (this year)-6.82%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+54.30%
P/E ratioNM
Price/Sales6.20
Price/Book2.83

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...+0.19+3.40%
TTHITransition Therapeut...+0.20+10.15%
TRILTrillium Therapeutic...+0.40+2.55%
ERBERBA Diagnostics Inc+0.03+1.81%
Data as of 4:05pm ET, 08/28/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$10.2M
Annual profit (last year)-$16.6M
Net profit margin-163.18%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
President, Chief Executive Officer &
Director
Panna L. Sharma
Vice President-
Operations
Robert Fannon
Corporate headquarters
Rutherford, New Jersey

Forecasts

Partner Offers